Hofmann, S., Schmidt, M. A., Weissmann, T., Eyüpoglu, I., Strnad, A., Semrau, S., . . . Lettmaier, S. (2020). Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: A retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider. J Neurooncol.
Chicago Style aipamenaHofmann, Susanne, Manuel Alexander Schmidt, Thomas Weissmann, Ilker Eyüpoglu, Annedore Strnad, Sabine Semrau, Rainer Fietkau, Florian Putz, and Sebastian Lettmaier. "Evidence for Improved Survival With Bevacizumab Treatment in Recurrent High-grade Gliomas: A Retrospective Study With (“pseudo-randomized”) Treatment Allocation By the Health Insurance Provider." J Neurooncol 2020.
MLA aipamenaHofmann, Susanne, et al. "Evidence for Improved Survival With Bevacizumab Treatment in Recurrent High-grade Gliomas: A Retrospective Study With (“pseudo-randomized”) Treatment Allocation By the Health Insurance Provider." J Neurooncol 2020.